In this study, we reveal a previously unidentified role of KDM3A in promoting pathological ventricular remodeling, and corresponding anti-cardiac hypertrophy/remodeling efficacy of the KDM inhibitor JIB-04. The gene discussed is KDM3A; the disease is cardiac hypertrophy.